CARLSBAD, Calif.--(BUSINESS WIRE)--Invitrogen Corporation (Nasdaq:IVGN) today announced that Per Peterson, M.D., Ph.D. has been appointed to its board of directors, effective March 1, 2007. Dr. Peterson recently retired as Chairman, Research & Development, at Johnson & Johnson. As Chairman, he had responsibility for the Corporate Office of Science and Technology, the Enterprise-wide R&D Council, and Johnson & Johnson’s cell therapy research activities. Dr. Peterson was also a member of the Executive Committee of Johnson & Johnson.
